Encision Stock

Encision Cash Conversion Cycle

Delisted·Jul 10, 2026

The Cash Conversion Cycle (CCC) of Encision (ECIA) as of Aug 16, 2026 is 116.68. In the previous year, Cash Conversion Cycle (CCC) was 180.04 — a change of -35.19% (lower).

Cash Conversion Cycle

116.68

YoY

-35.19%

Last updated:

Cash Conversion Cycle (CCC) of Encision is 2026 116.68 . Cash Conversion Cycle (CCC) of Encision was 2025 180.04 . It decreases by -35.19% lower compared to the previous year.
Access this data via the Eulerpool API

Encision Stock analysis

What does Encision do? Encision Inc is a leading provider of precision instruments for minimally invasive surgery, based in Boulder, Colorado. The company's history can be traced back to 1991 when it was founded by Kenneth Messier, an experienced surgeon. At that time, minimally invasive surgery was becoming increasingly popular as it offered patients smaller scars and less pain. However, the technology was not yet perfected and problems, particularly with the use of high-frequency electrocautery, kept arising. Messier recognized this problem and developed an innovative solution: AEM technology (Active Electrode Monitoring). Together with a colleague, Mark Weinstein, he founded Encision Inc to bring this technology to the market. Since then, the company has evolved into a leading provider of precision tools for minimally invasive surgery. Encision's business model is based on the production and distribution of medical devices and related consumables. Encision offers a wide range of surgical instruments, including AEM and non-AEM electrocautery devices, surgical monitors, fine cutting instruments, and trocars. These devices are used in various surgical disciplines such as gynecology, urology, and general medicine. One of Encision's main areas of focus is AEM technology, which reduces the risk of unintentional tissue burns during electrocautery. The AEM system continuously monitors the electrical impedance of the tissue and adjusts the high-frequency power as needed. Another important area for Encision is the development of disposable products such as electrodes, needles, and tubing sets. These products are intended for single-use and help minimize infection risks. Encision has also specialized in the development of instruments for laparoscopic surgery, a minimally invasive technique in which the operation is performed through small incisions in the body. Encision's laparoscopy instruments offer precise control and high performance to meet the demands of surgeons. Encision has sold over 2,500 devices to clinics and healthcare providers in North America and Europe. Most of the products are registered and certified in the USA. Encision places great emphasis on quality and innovation. The company has strict quality control measures to maintain the highest standards in production and the development of new products. Furthermore, it is committed to constantly developing new technologies and expanding its portfolio to meet customer needs. Overall, Encision Inc has experienced strong growth in recent years and has become a leading provider of surgical instruments in the minimally invasive surgery industry. With its focus on quality, innovation, and customer satisfaction, the company has built a solid reputation in the industry and is expected to continue being a key player in the future. The answer is "Encision Inc is a leading provider of precision instruments for minimally invasive surgery, based in Boulder, Colorado." Encision is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Encision stock

Cash Conversion Cycle (CCC) of Encision is 116.68 in 2026.

Cash Conversion Cycle (CCC) of Encision changed from 180.04 to 116.68, representing a -35.19% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Cash Conversion Cycle (CCC) Encision since 2006 – with annual values, charts, and detailed analysis.

The Cash Conversion Cycle measures how long it takes to convert inventory investments into cash from sales. A shorter CCC indicates more efficient working capital management.

CCC = DSO + DIO - DPO

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Conversion Cycle (CCC)'s Encision with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Conversion Cycle (CCC)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Conversion Cycle (CCC).

Access this data via the Eulerpool API

Profitability — Encision

All Key Metrics — Encision